Status:
COMPLETED
Studies of Inherited Diseases of Metabolism
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Multiple Endocrine Neoplasia
Eligibility:
All Genders
4+ years
Brief Summary
Diseases of mineral metabolism such as familial multiple endocrine neoplasia type 1 (FMEN1), familial hypocaliuric hypercalcemia (FHH), familial hyperparathyroidism (FH), and pseudohypoparathyroidism ...
Detailed Description
Familial multiple endocrine neoplasia type 1 (MEN1), familial hypocalciuric (or familial benign) hypercalcemia (FHH), hyperparathyroidism - jaw tumor syndrome (HPT-JT), other causes of familial isolat...
Eligibility Criteria
-
ELIGIBILITY CRITERIA:
- Patient has possible form of familial hyperparathyroidism. Or case is a clinically unaffected first degree relative of such a patient.
- The lower age limit to enter a clinically affected minor into the study is >= 4 years old. However, asymptomatic and possibly unaffected cases will not be enrolled, and blood will not be drawn, before age 5 years in MEN1, MEN1-like, HPT-JT, or FIHP kindreds or before age 10 in FHH kindreds.
Key Trial Info
Start Date :
August 19 1993
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 13 2023
Estimated Enrollment :
969 Patients enrolled
Trial Details
Trial ID
NCT00001345
Start Date
August 19 1993
End Date
January 13 2023
Last Update
January 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892